Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leiomyosarcoma × sargramostim × Clear all

Sponsor

Conditions

Leukemia 16 Lymphoma 10 Leukemia, Myeloid, Acute 9 Breast Neoplasms 9 Neuroblastoma 8 Myelodysplastic Syndromes 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Ovarian Neoplasms 7 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Multiple Myeloma 6 Melanoma 6 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Osteosarcoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Ganglioneuroblastoma 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Hodgkin Disease 2 Gliosarcoma 2

Interventions

Doxorubicin 6 pazopanib 4 Trabectedin 3 Sorafenib 3 Gemcitabine 3 Docetaxel 3 Dacarbazine 3 pembrolizumab 2 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 Nivolumab 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 tremelimumab 1 temsirolimus 1 saracatinib 1 rucaparib 1 romidepsin 1 olaratumab 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 durvalumab 1 cixutumumab 1 berzosertib 1 avelumab 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡